Researchers at UT Southwestern Medical Center have discovered a way to target a specific population of bacteria that promotes gut inflammation in mice. While more studies are needed, they believe the discovery could lead to a new target for therapy development.
Scientists refer to the strategy as the “precision editing” of the gut microbiome, which helped reduce inflammation in a mouse model of colitis without affecting other bacterial populations that are important for overall intestinal health. While the strategy is not yet safe for application in humans, it provides proof-of-principle to develop future bacteria-targeted therapeutics for inflammatory bowel disease (IBD).
Read more at: IBD News Today